Wed, January 25, 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos
[ Wed, Jan 25th 2012 ] - Market Wire
CORRECTING and REPLACING Glancy Binkow & Goldberg LLP Announces Investigation of Illumina, Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del
[ Wed, Jan 25th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Illumina Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Thoratec Schedules Fourth Quarter Conference Call, Webcast
[ Wed, Jan 25th 2012 ] - Market Wire
Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk
[ Wed, Jan 25th 2012 ] - Market Wire
Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854
[ Wed, Jan 25th 2012 ] - Market Wire
Medtronic and Guided Therapeutics Poised for Growth
[ Wed, Jan 25th 2012 ] - Market Wire
Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro
[ Wed, Jan 25th 2012 ] - Market Wire
Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor
[ Wed, Jan 25th 2012 ] - Market Wire
Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508
[ Wed, Jan 25th 2012 ] - Market Wire
DaVita Acquires Majority Stake in NephroLife India
[ Wed, Jan 25th 2012 ] - Market Wire
Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe
Tue, January 24, 2012
[ Tue, Jan 24th 2012 ] - Market Wire
Quarterly Report I 11/12
[ Tue, Jan 24th 2012 ] - Market Wire
Codexis Announces CFO Departure
[ Tue, Jan 24th 2012 ] - Market Wire
Mylan to Host Investor Day on Feb. 21, 2012, in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
Cleveland BioLabs Announces Management Reorganization
[ Tue, Jan 24th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates
[ Tue, Jan 24th 2012 ] - Market Wire
Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors
[ Tue, Jan 24th 2012 ] - Market Wire
Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem
[ Tue, Jan 24th 2012 ] - Market Wire
Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry
[ Tue, Jan 24th 2012 ] - Market Wire
Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients
[ Tue, Jan 24th 2012 ] - Market Wire
Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T
[ Tue, Jan 24th 2012 ] - Market Wire
Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter
[ Tue, Jan 24th 2012 ] - Market Wire
BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C
[ Tue, Jan 24th 2012 ] - Market Wire
PDL BioPharma Announces 2012 Regular Quarterly Dividends
[ Tue, Jan 24th 2012 ] - Market Wire
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
[ Tue, Jan 24th 2012 ] - Market Wire
Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen
[ Tue, Jan 24th 2012 ] - Market Wire
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
OncoSec to Present at World Cancer Immunotherapy Conference
[ Tue, Jan 24th 2012 ] - Market Wire
Dhr. Richard W. Barker wordt lid Raad van Bestuur van Celgene Corporation
Mon, January 23, 2012
[ Mon, Jan 23rd 2012 ] - Market Wire
Revoici la dpche corrige : Celgene Corporation li .. W. Barker, D. Phil., son conseil d'administration
[ Mon, Jan 23rd 2012 ] - Market Wire
Celgene Corporation incorpora a su Consejo de Administracin al Dr. Richard W. Barker
[ Mon, Jan 23rd 2012 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc.
[ Mon, Jan 23rd 2012 ] - Market Wire
Fresh Start Private Renews Advertising Agreement With Clear Channel Los Angeles Until 2013
[ Mon, Jan 23rd 2012 ] - Market Wire
UnitedHealth Group, The Goldman Sachs, Tiffany & Company, News Corporation and School Specialty
[ Mon, Jan 23rd 2012 ] - Market Wire
Verisante Aura Clinical Study Data Analysis Presented at SPIE
[ Mon, Jan 23rd 2012 ] - Market Wire
OPKO Health Acquires Next Generation Prostate Cancer Tests
[ Mon, Jan 23rd 2012 ] - Market Wire
Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
[ Mon, Jan 23rd 2012 ] - Market Wire
Canada's First National Public Cord Blood Bank Ad .. ThermoGenesis BioArchive Cryopreservation System
[ Mon, Jan 23rd 2012 ] - Market Wire
MyMedicalRecords to Introduce Mobile Phone and Tablet App at HIMSS
[ Mon, Jan 23rd 2012 ] - Market Wire
Boston Scientific Announces Favorable Ruling in Patent Infringement Case
[ Mon, Jan 23rd 2012 ] - Market Wire
Amarantus BioSciences Licenses Parkinsonas Diseas .. ostic Biomarker Test from Power3 Medical Products
[ Mon, Jan 23rd 2012 ] - Market Wire
The Medicines Company Settles Angiomax(R) (Bivali .. udin) Patent Litigations With App Pharmaceuticals
[ Mon, Jan 23rd 2012 ] - Market Wire
EntreMed Secures $10 Million Strategic Financing
[ Mon, Jan 23rd 2012 ] - Market Wire
Marina Biotech Receives Notice of Acceptance for .. g Its Unlocked Nucleobase Analog (UNA) Technology
[ Mon, Jan 23rd 2012 ] - Market Wire
BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
PAREXEL Expands Alliance Network to Support Early .. lishes Collaboration With University Hospitals Br
Sun, January 22, 2012
[ Sun, Jan 22nd 2012 ] - Market Wire
Helix BioPharma Corp. Responds to Dissident Proxy .. ion With the January 30, 2012 Shareholder Meeting
Sat, January 21, 2012
[ Sat, Jan 21st 2012 ] - Market Wire
L'FDA aggiorna l'etichetta del TYSABRI (natalizum .. egli anticorpi anti-JCV come fattore di rischio d
[ Sat, Jan 21st 2012 ] - Market Wire
FDA aktualisiert Produktinformationen fr TYSABRI .. des JC-Virus-Antikrperstatus als Risikofaktor fr
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l' .. zumab) pour y inclure le statut daanticorps anti-
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. de TYSABRI (natalizumab) pour y inclure le statut
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;tiquetage de TYSABRI (natalizumab) p
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;tiquetage de TYSABRI (na
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;tiquetage de TYS
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;tiquetage de
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;tiquetag
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;tiqu
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
Fri, January 20, 2012
[ Fri, Jan 20th 2012 ] - Market Wire
Select Medical Holdings Corporation to Announce F .. d Full Year 2011 Results on Thursday, February 23
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Advisory Committee Declines to Recommend Appr .. Gel 8% for the Reduction of Risk of Preterm Birth
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Updates TYSABRI (natalizumab) Label to Includ .. nti-JC Virus Antibody Status as a PML Risk Factor
[ Fri, Jan 20th 2012 ] - Market Wire
Bestuursvoorzitter van Covidien gekozen tot Voorzitter van de Raad
[ Fri, Jan 20th 2012 ] - Market Wire
Waters and NIBRT Complete Work on World's First UPLC Glycan Database
[ Fri, Jan 20th 2012 ] - Market Wire
Sequenom Prices Public Offering of Common Stock
[ Fri, Jan 20th 2012 ] - Market Wire
Amerigroup Corporation to Discuss Fourth Quarter Earnings on February 17
[ Fri, Jan 20th 2012 ] - Market Wire
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
[ Fri, Jan 20th 2012 ] - Market Wire
Hartford Hospital Selected as a Hansen Medical "C .. llence" for Sensei(R) X Robotic Catheter Platform
[ Fri, Jan 20th 2012 ] - Market Wire
Genomic Health Presents Results From First Clinic .. ncotype DX Colon Cancer at the 2012 Gastrointesti
[ Fri, Jan 20th 2012 ] - Market Wire
Insmed Incorporated Provides Corporate Update
[ Fri, Jan 20th 2012 ] - Market Wire
Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN
[ Fri, Jan 20th 2012 ] - Market Wire
Director general de Covidien designado presidente del Directorio
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien CEO Elected Chairman of the Board
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien: amministartore delegato eletto presidente del consiglio d'amministrazione
[ Fri, Jan 20th 2012 ] - Market Wire
Le PDG de Covidien est lu prsident du conseil daadministration
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien-CEO zum Chairman of the Board gewhlt
Thu, January 19, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
LaAgenzia per gli Alimenti e i Medicinali statuni .. tration, FDA) approva delle nuove formulazioni di
[ Thu, Jan 19th 2012 ] - Market Wire
Cannabis Science Updates Second Medical Cannabis .. Squamous Cell Carcinoma Photo-documents Cannabis
[ Thu, Jan 19th 2012 ] - Market Wire
Holzer Holzer & Fistel, LLC Announces Investigati .. Breaches of Fiduciary Duty by Certain Officers an
[ Thu, Jan 19th 2012 ] - Market Wire
Tenet Announces New Agreement with Blue Cross and Blue Shield of Illinois
[ Thu, Jan 19th 2012 ] - Market Wire
Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
[ Thu, Jan 19th 2012 ] - Market Wire
Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for Fourth Consecutive Year
[ Thu, Jan 19th 2012 ] - Market Wire
ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
[ Thu, Jan 19th 2012 ] - Market Wire
Magellan Health Services and Phoenix Health Plan Announce Joint Venture Development Agreement
[ Thu, Jan 19th 2012 ] - Market Wire
Community Health Systems, Inc. Announces Its Inte .. ent of Its Existing Credit Agreement and Extensio
[ Thu, Jan 19th 2012 ] - Market Wire
ARCA biopharma Announces Additional Patent Issued .. ment with Bucindolol Based on Genotype of Patient
[ Thu, Jan 19th 2012 ] - Market Wire
OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium
[ Thu, Jan 19th 2012 ] - Market Wire
Nordion Enters Six-Year Cobalt-60 Supply Agreement with Synergy Health
[ Thu, Jan 19th 2012 ] - Market Wire
Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26
[ Thu, Jan 19th 2012 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-H150 Deployed at Major International Bank in Middle East
[ Thu, Jan 19th 2012 ] - Market Wire
Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
Adeona Announces Initiation of Phase II Clinical .. " for Cognitive Dysfunction in Multiple Sclerosis
[ Thu, Jan 19th 2012 ] - Market Wire
Kraig Biocraft Laboratories Announces New CEO Interview
Wed, January 18, 2012
[ Wed, Jan 18th 2012 ] - Market Wire
Astellas und XenoPort geben japanische Zulassung .. ite-Tabletten gegen Restless-Legs-Syndrom bekannt
[ Wed, Jan 18th 2012 ] - Market Wire
Bond Labs Launches Innovative New Product Stack
[ Wed, Jan 18th 2012 ] - Market Wire
Brain Cancer Patient Receives First TrueBeam STx .. ment in Asia at BGS Global Hospitals in Bangalore
[ Wed, Jan 18th 2012 ] - Market Wire
Astellas e XenoPort annunciano l'approvazione del .. per il trattamento della sindrome delle gambe se
[ Wed, Jan 18th 2012 ] - Market Wire
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
[ Wed, Jan 18th 2012 ] - Market Wire
Cynosure to Host Fourth-Quarter 2011 Financial Results Conference Call on February 14
[ Wed, Jan 18th 2012 ] - Market Wire
Comprehensive Care Corp. (CHCR) Completes Its Network Across Puerto Rico
[ Wed, Jan 18th 2012 ] - Market Wire
Prestige Brands, Inc. Announces Offering of $290 Million Senior Notes
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences perfeziona laacquisizione di Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Abschluss der bernahme von Pharmasset, Inc., durch Gilead Sciences
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences completa adquisicin de Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Biomerica Announces Second Quarter Financial Results
[ Wed, Jan 18th 2012 ] - Market Wire
Given Imaging to Host Fourth Quarter and Full-Year 2011 Financial Results Conference Calls
[ Wed, Jan 18th 2012 ] - Market Wire
Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine
[ Wed, Jan 18th 2012 ] - Market Wire
Bioline Introduces HyperPAGE II Broad Range Prestained Protein Marker
[ Wed, Jan 18th 2012 ] - Market Wire
OncoSec Provides Company Update and Announces 2012 Goals
[ Wed, Jan 18th 2012 ] - Market Wire
Perceptive Informatics Medical Imaging Services Receive Top Ratings
Tue, January 17, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
The Medicines Company's Cangrelor Bridge Trial Pu .. n the Journal of the American Medical Association
[ Tue, Jan 17th 2012 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. rnings Release Date for Tuesday, February 7, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Graymark Healthcare Partners With Emory Universit .. anta, Georgia to Deliver Comprehensive Sleep Care
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson & Johnson to Host Analyst Meeting to Disc .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson amp;; Johnson to Host Analyst Meet .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Alnylam Files Patent Infringement Suit Against Tekmira
[ Tue, Jan 17th 2012 ] - Market Wire
Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613
[ Tue, Jan 17th 2012 ] - Market Wire
Cytomedix Appoints Cathryn Hope as Vice President of Marketing
[ Tue, Jan 17th 2012 ] - Market Wire
ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan
[ Tue, Jan 17th 2012 ] - Market Wire
Palatin Technologies Receives $1.1 Million From Sale of New Jersey State Tax Credits
[ Tue, Jan 17th 2012 ] - Market Wire
MAP Pharmaceuticals Appoints W. James O'Shea to Board of Directors
[ Tue, Jan 17th 2012 ] - Market Wire
Akorn Provides Financial Guidance for 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Medivation and Pfizer Announce Results From Phase .. 3 Concert Trial of Dimebon in Alzheimer's Disease
[ Tue, Jan 17th 2012 ] - Market Wire
Illumina to Announce Fourth Quarter and Fiscal Ye .. 11 Financial Results on Tuesday, January 31, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Health Management Associates, Inc. Provides Addit .. to Recently Announced General Counsel Resignation
[ Tue, Jan 17th 2012 ] - Market Wire
OncoSec Medical President and CEO Contributes to Drug Discovery News
[ Tue, Jan 17th 2012 ] - Market Wire
PAREXEL Appoints Former Senior FDA Official David .. er to Global Team of Strategic Compliance Experts
Mon, January 16, 2012
[ Mon, Jan 16th 2012 ] - Market Wire
ISTA's Board of Directors to Review Valeant's Rev .. s Part of Its Ongoing Review of Strategic Options
[ Mon, Jan 16th 2012 ] - Market Wire
Array BioPharma's Chief Executive Officer Robert E. Conway Resigns
[ Mon, Jan 16th 2012 ] - Market Wire
Life Technologies Partners With DaAn Gene to Deve .. ommercialize Molecular Diagnostic Assays in China
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contre-indique lautilisation de Duet TRS .. irurgie thoracique et procde un rappel volontaire
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien kontraindiziert Duet TRSTM fr Thoraxchirurgie und startet freiwillige Rckrufaktion
[ Mon, Jan 16th 2012 ] - Market Wire
Luminex Corporation Fourth Quarter and Full Year .. 1 Earnings Release Scheduled for February 6, 2012
[ Mon, Jan 16th 2012 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. iduciary Duty by the Officers and Directors of Ch
[ Mon, Jan 16th 2012 ] - Market Wire
Sycamore Entertainment Group Inc. Acquires US Dis .. F THE STORM, Starring Academy Award Winner Geoffr
[ Mon, Jan 16th 2012 ] - Market Wire
Questcor Pharmaceuticals Responds to Questions From Investor Blog
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contraindica el uso del sistema Duet TRS .. a e implementa su retirada voluntaria del mercado
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contraindica o uso de Duet TRSTM para cirurgia torcica e convoca um recall voluntrio
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien geeft contra-indicatie voor gebruik van .. rurgie, Het voert een vrijwillige terugroeping ui
[ Mon, Jan 16th 2012 ] - Market Wire
MSA Declares First Quarter Dividend
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien mette in guardia contro lauso del Duet T .. hirurgia toracica e ne attua il ritiro volontario
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien Contraindicates the Use of Duet TRSTM for Thoracic Surgery, Implements a Voluntary Recall
[ Mon, Jan 16th 2012 ] - Market Wire
Neogen Develops Simple, Precise Test for Mold Toxin Zearalenone
[ Mon, Jan 16th 2012 ] - Market Wire
Palatin Technologies to Present at BOCEMb, Noble .. Capital Markets' Eighth Annual Equity Conference
Fri, January 13, 2012
[ Fri, Jan 13th 2012 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Chemed Corporation (NYS
[ Fri, Jan 13th 2012 ] - Market Wire
Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
[ Fri, Jan 13th 2012 ] - Market Wire
January 30, 2012
[ Fri, Jan 13th 2012 ] - Market Wire
Prestige Brands, Inc. Announces Proposed Offering of $290 Million Senior Notes
[ Fri, Jan 13th 2012 ] - Market Wire
The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of In
[ Fri, Jan 13th 2012 ] - Market Wire
Critical Alerts for Celgene, DirecTV, Goldcorp, T .. , and Coinstar Released by Seven Summits Research
[ Fri, Jan 13th 2012 ] - Market Wire
Humana, Guess?, Tractor Supply Company, Chevron and PVH
[ Fri, Jan 13th 2012 ] - Market Wire
Omni Bio to Conduct New Human Clinical Trials
[ Fri, Jan 13th 2012 ] - Market Wire
A Forward Look, the Year Ahead -- Featured Research on Mylan Inc. and Cloud Peak Energy Inc.
[ Fri, Jan 13th 2012 ] - Market Wire
A Forward Look, the Year Ahead -- Featured Resear .. ion Pharmaceuticals, Inc. and Nektar Therapeutics
[ Fri, Jan 13th 2012 ] - Market Wire
Savient Pharmaceuticals Appoints Experienced Phar .. tive, David Veitch as President of Savient Europe
[ Fri, Jan 13th 2012 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. -- Healthcare Providers Continuing Momentum
[ Fri, Jan 13th 2012 ] - Market Wire
MYTHOS Trial of PLC's RenalGuard Article Published in JACC -- Cardiovascular Interventions
[ Fri, Jan 13th 2012 ] - Market Wire
Health Canada Grants Priority Review Status For N .. ission (NDS) For Cinryzea" (C1 Inhibitor [human])
[ Fri, Jan 13th 2012 ] - Market Wire
Seattle Genetics Announces Updates to ADCETRISa" Prescribing Information
[ Fri, Jan 13th 2012 ] - Market Wire
Covidien??Mark Trudeau??????????
[ Fri, Jan 13th 2012 ] - Market Wire
Covidien benoemt Mark Trudeau tot president van farmaceutisch segment
Thu, January 12, 2012
[ Thu, Jan 12th 2012 ] - Market Wire
Gilead Sciences voltooit aanbod voor alle uitstaande aandelen van Pharmasset, Inc.
[ Thu, Jan 12th 2012 ] - Market Wire
Cantel Medical Corp. Announces 3-for-2 Stock Split
[ Thu, Jan 12th 2012 ] - Market Wire
Block & Leviton LLP Investigates Possible Securit .. Claims Against Health Management Associates, Inc.
[ Thu, Jan 12th 2012 ] - Market Wire
Daxor Announces That the Mayo Clinic in Scottsdale, Arizona Acquires BVA-100 Blood Volume Analyzer
[ Thu, Jan 12th 2012 ] - Market Wire
Amerigroup Announces Proposed Add-On Offering of $50 Million of Its 7.50% Senior Notes due 2019
[ Thu, Jan 12th 2012 ] - Market Wire
Perrigo Wins Summary Judgment in Generic Mucinex Case
[ Thu, Jan 12th 2012 ] - Market Wire
Health Net Community Solutions Centers Offer Free .. llness Activities to Local Communities They Serve
[ Thu, Jan 12th 2012 ] - Market Wire
Obesity Drug Candidates From Arena Pharmaceuticals and Vivus Look to Make Big Splash in 2012
[ Thu, Jan 12th 2012 ] - Market Wire
WeedMaps Media Completes Acquisition of Leading Medicinal Cannabis Software Company
[ Thu, Jan 12th 2012 ] - Market Wire
Chief Operating Officer Tessie M. Che Departing Company
[ Thu, Jan 12th 2012 ] - Market Wire
Synta Pharmaceuticals and University of Toronto R .. ol Mechanism of Action Using Innovative Yeast-bas
[ Thu, Jan 12th 2012 ] - Market Wire
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien dona otro milln de dlares a un hospital de Hait
[ Thu, Jan 12th 2012 ] - Market Wire
MedPro Safety Products Strengthens Senior Management Team
[ Thu, Jan 12th 2012 ] - Market Wire
LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien doa mais US$ 1 milho para ajudar hospital haitiano
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien spendet eine weitere Million US-Dollar fr Krankenhaus in Haiti
Wed, January 11, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc.
[ Wed, Jan 11th 2012 ] - Market Wire
Covidien fait don daun million de dollars supplmentaires pour soutenir un h'pital hatien
[ Wed, Jan 11th 2012 ] - Market Wire
Vanguard Health Systems to Report Second Quarter Fiscal 2012 Results on February 1, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by BioSante Pharmaceut
[ Wed, Jan 11th 2012 ] - Market Wire
MEDNAX 2011 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 2, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit
[ Wed, Jan 11th 2012 ] - Market Wire
Covidien dona un altro milione di dollari per aiutare l'ospedale di Haiti
[ Wed, Jan 11th 2012 ] - Market Wire
Counsel for Former Matria Healthcare Chairman and CEO Parker H. Petit Deny SEC Claims
[ Wed, Jan 11th 2012 ] - Market Wire
Synta Pharmaceuticals Closes Public Offering of Common Stock
[ Wed, Jan 11th 2012 ] - Market Wire
PharmAthene to Present at the Noble Financial Eig .. al Equity Conference on Tuesday, January 17, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
Bacterin to Present at the Noble 8th Annual Equity Conference on January 17, 2012

Covidien divulga dividendos trimestrais em dinheiro


//health-fitness.news-articles.net/content/2012/ .. -divulga-dividendos-trimestrais-em-dinheiro.html
Published in Health and Fitness on Thursday, January 19th 2012 at 13:06 GMT by Market Wire   Print publication without navigation


DUBLIN--([ ])--A Covidien plc (NYSE: COV) anunciou hoje que a Diretoria da companhia divulgou um dividendo trimestral em dinheiro de US$ 0,225 por ao ordinria. O dividendo ser pagvel aos acionistas no dia 22 de fevereiro de 2012, de acordo com os registros de 30 de janeiro de 2012.

SOBRE A COVIDIEN

A Covidien uma companhia lder global em produtos de assistncia sade que cria solues mdicas inovadoras para alcanar melhores resultados para os pacientes, distribuindo valor atravs de liderana e excelncia clnica. A Covidien fabrica, distribui e atende uma ampla variedade de linhas de produtos lderes no setor, em trs segmentos: Equipamentos Mdicos, Farmacutica e Suprimentos Mdicos. Com uma receita de US$ 11,6 bilhes em 2011, a Covidien conta com 41.000 funcionrios em mais de 65 pases em todo o mundo e seus produtos so vendidos em mais de 140 pases. Para saber mais sobre nossas reas de negcios, visite o web site [ www.covidien.com ].

O texto no idioma original deste anncio a verso oficial autorizada. As tradues so fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que a nica verso do texto que tem efeito legal.


Publication Contributing Sources